Literature DB >> 25174636

'Children will always be children': exploring perceptions and experiences of HIV-positive children who may not take their treatment and why they may not tell.

Rachel Kawuma1, Sarah Bernays, Godfrey Siu, Tim Rhodes, Janet Seeley.   

Abstract

HIV-positive children and young people may face substantial social barriers to maintaining appropriate levels of adherence to antiretroviral therapy (ART) during childhood and adolescence. In this paper, we focus on these children's voices and the challenges they face growing up living with HIV in Uganda. Drawing on retrospective self-reports of 26 children living with HIV, taking ART and attending a clinic in central Uganda, we examine the reasons for non-adherence to ART among children and why they may not report when they miss their treatment. The reasons why children may not take their treatment are socially complex and similar to adult experiences and the struggles people face in adhering to life-long treatment of a condition that is stigmatised. Children are aware of the stigma that surrounds their condition and respond to adults who stress the importance of keeping their condition secret. The causes of non-adherence are not necessarily due to forgetting, but because of concerns about secrecy and children deliberately avoiding being seen taking their treatment, for example, to avoid identification. Children's desire to maintain and protect relationships explains non-adherence as well as their failure to report it to adults. The clinical focus on exemplary adherence makes it more difficult for healthcare workers to discuss with children the social challenges that they may experience in taking treatment every day. If adults could approach non-adherence with greater empathy, recognising that children too are juggling treatment taking and social concerns then children may feel more willing to tell them about missed doses. Their poor adherence is not an inevitable element of the experience of being a child, but rather, like many adults, a substantial challenge if they are to manage their life-long treatment.

Entities:  

Keywords:  Africa; HIV and AIDS; Uganda; adherence; adolescents; antiretroviral therapy; children

Mesh:

Substances:

Year:  2014        PMID: 25174636     DOI: 10.2989/16085906.2014.927778

Source DB:  PubMed          Journal:  Afr J AIDS Res        ISSN: 1608-5906            Impact factor:   1.300


  22 in total

1.  Discontinuation of Efavirenz in Paediatric Patients: Why do Children Switch?

Authors:  Elke Wynberg; Eleri Williams; Gareth Tudor-Williams; Hermione Lyall; Caroline Foster
Journal:  Clin Drug Investig       Date:  2018-03       Impact factor: 2.859

2.  The Medical Research Council (UK)/Uganda Virus Research Institute Uganda Research Unit on AIDS--'25 years of research through partnerships'.

Authors:  P Kaleebu; A Kamali; J Seeley; A M Elliott; E Katongole-Mbidde
Journal:  Trop Med Int Health       Date:  2014-10-29       Impact factor: 2.622

3.  When information does not suffice: young people living with HIV and communication about ART adherence in the clinic.

Authors:  S Bernays; S Paparini; D Gibb; J Seeley
Journal:  Vulnerable Child Youth Stud       Date:  2015-12-30

4.  Qualitative study of the BREATHER trial (Short Cycle antiretroviral therapy): is it acceptable to young people living with HIV?

Authors:  Sarah Bernays; Sara Paparini; Janet Seeley; Stella Namukwaya Kihika; Diana Gibb; Tim Rhodes
Journal:  BMJ Open       Date:  2017-02-17       Impact factor: 2.692

5.  Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand.

Authors:  Luyi Xu; Kerim Munir; Cheeraya Kanabkaew; Sophie Le Coeur
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

6.  Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents and young adults (BREATHER): Extended follow-up results of a randomised, open-label, non-inferiority trial.

Authors:  Anna Turkova; Cecilia L Moore; Karina Butler; Alexandra Compagnucci; Yacine Saïdi; Victor Musiime; Annet Nanduudu; Elizabeth Kaudha; Tim R Cressey; Suwalai Chalermpantmetagul; Karen Scott; Lynda Harper; Samuel Montero; Yoann Riault; Torsak Bunupuradah; Alla Volokha; Patricia M Flynn; Rosa Bologna; Jose T Ramos Amador; Steven B Welch; Eleni Nastouli; Nigel Klein; Carlo Giaquinto; Deborah Ford; Abdel Babiker; Diana M Gibb
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

7.  Virological failure on first-line antiretroviral therapy; associated factors and a pragmatic approach for switching to second line therapy-evidence from a prospective cohort study in rural South-Western Uganda, 2004-2011.

Authors:  Patrick Kazooba; Billy Nsubuga Mayanja; Jonathan Levin; Ben Masiira; Pontiano Kaleebu
Journal:  Pan Afr Med J       Date:  2018-04-02

8.  "How Do We Start? And How Will They React?" Disclosing to Young People with Perinatally Acquired HIV in Uganda.

Authors:  Stella Namukwaya; Sara Paparini; Janet Seeley; Sarah Bernays
Journal:  Front Public Health       Date:  2017-12-13

9.  Exploring the care relationship between grandparents/older carers and children infected with HIV in south-western Uganda: implications for care for both the children and their older carers.

Authors:  Rwamahe Rutakumwa; Flavia Zalwango; Esther Richards; Janet Seeley
Journal:  Int J Environ Res Public Health       Date:  2015-02-13       Impact factor: 3.390

10.  Factors Associated With Nonadherence to Antiretroviral Therapy Among Young People Living With Perinatally Acquired HIV in England.

Authors:  Ali Judd; Diane Melvin; Lindsay C Thompson; Caroline Foster; Marthe Le Prevost; Michael Evangeli; Alan Winston; Alejandro Arenas-Pinto; Kate Sturgeon; Katie Rowson; Diana M Gibb; Hannah Castro
Journal:  J Assoc Nurses AIDS Care       Date:  2020 Sep-Oct       Impact factor: 1.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.